ANDREW R. SAIK

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Milestone Pharmaceuticals Inc.

Filing Date Source Excerpt
2024-07-15 "Additionally, Mr. Saik brings extensive management experience in IT, business development and investor relations."

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-04-14